134 related articles for article (PubMed ID: 10386179)
1. Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder.
Anand A; Darnell A; Miller HL; Berman RM; Cappiello A; Oren DA; Woods SW; Charney DS
Biol Psychiatry; 1999 Apr; 45(8):972-8. PubMed ID: 10386179
[TBL] [Abstract][Full Text] [Related]
2. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?
Berman RM; Narasimhan M; Miller HL; Anand A; Cappiello A; Oren DA; Heninger GR; Charney DS
Arch Gen Psychiatry; 1999 May; 56(5):395-403. PubMed ID: 10232292
[TBL] [Abstract][Full Text] [Related]
3. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
Tohen M; Wang WV; Leboyer M; Jen KY
J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
[TBL] [Abstract][Full Text] [Related]
4. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
7. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
Nolen WA; Weisler RH
Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
[TBL] [Abstract][Full Text] [Related]
8. Predictors of relapse or recurrence in bipolar I disorder.
Degenhardt EK; Gatz JL; Jacob J; Tohen M
J Affect Disord; 2012 Feb; 136(3):733-9. PubMed ID: 22036802
[TBL] [Abstract][Full Text] [Related]
9. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
Yoshimura R; Ueda N; Shinkai K; Nakamura J
Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
[TBL] [Abstract][Full Text] [Related]
10. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
[TBL] [Abstract][Full Text] [Related]
11. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy.
Neumeister A; Turner EH; Matthews JR; Postolache TT; Barnett RL; Rauh M; Vetticad RG; Kasper S; Rosenthal NE
Arch Gen Psychiatry; 1998 Jun; 55(6):524-30. PubMed ID: 9633671
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remission.
Lam RW; Tam EM; Grewal A; Yatham LN
Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S97-101. PubMed ID: 11682283
[TBL] [Abstract][Full Text] [Related]
14. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
[TBL] [Abstract][Full Text] [Related]
15. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
Tohen M; Chengappa KN; Suppes T; Baker RW; Zarate CA; Bowden CL; Sachs GS; Kupfer DJ; Ghaemi SN; Feldman PD; Risser RC; Evans AR; Calabrese JR
Br J Psychiatry; 2004 Apr; 184():337-45. PubMed ID: 15056579
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute tryptophan depletion on mood and suicidal ideation in bipolar patients symptomatically stable on lithium.
Hughes JH; Dunne F; Young AH
Br J Psychiatry; 2000 Nov; 177():447-51. PubMed ID: 11059999
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan depletion in recently manic patients treated with lithium.
Cassidy F; Murry E; Carroll BJ
Biol Psychiatry; 1998 Feb; 43(3):230-2. PubMed ID: 9494705
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
[TBL] [Abstract][Full Text] [Related]
19. Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
Houston JP; Lipkovich IA; Ahl J; Rotelli MD; Baker RW; Bowden CL
J Psychiatr Res; 2007 Oct; 41(7):616-21. PubMed ID: 16236320
[TBL] [Abstract][Full Text] [Related]
20. Effect of alpha-methyl-para-tyrosine on response to cocaine challenge.
Stine SM; Krystal JH; Petrakis IL; Jatlow PI; Heninger GR; Kosten TR; Charney DS
Biol Psychiatry; 1997 Aug; 42(3):181-90. PubMed ID: 9232210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
